bpc-157 human trials safety Preclinical evaluation of body protective compound-157, a potential drug for treating various wounds BPC-157 Review: Doctor Explains Benefits,

A Phase 2 study published in The New England Journal of Medicine (Jastreboff et al., 2023) reported substantial weight reduction in participants with obesity

Let your doctor know if you experience severe or persistent headaches (per Medicover Hospitals)

Mild reactions (slight itching at injection site) often resolve with continued use

If thats your situation, ask your healthcare provider about other treatments that may ease your symptoms

Its human safety profile is not established there is no completed human trial

However, letrozole, anastrozole, and exemestane are newer-generation AIs that dominate the drug category